Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd announced a change in the director’s interest, specifically regarding Neville Gardiner’s indirect holdings. The announcement detailed the expiration of 250,000 unquoted options that were not exercised, impacting the director’s indirect interest holdings. This change reflects the company’s ongoing management of its securities and may influence stakeholder perceptions of the company’s governance practices.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development of advanced proteomics-based diagnostics and analytical services. The company is known for its innovative approaches in medical research and development, particularly in the area of protein analysis and biomarker discovery.
Average Trading Volume: 284,973
Technical Sentiment Signal: Sell
Current Market Cap: A$54.83M
Find detailed analytics on PIQ stock on TipRanks’ Stock Analysis page.